SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013756
Filing Date
2023-08-08
Accepted
2023-08-08 07:41:30
Documents
96
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-20230630x10q.htm   iXBRL 10-Q 2457090
2 EX-10.3 xoma-20230630xex10d3.htm EX-10.3 204379
3 EX-10.4 xoma-20230630xex10d4.htm EX-10.4 394015
4 EX-31.1 xoma-20230630xex31d1.htm EX-31.1 10612
5 EX-31.2 xoma-20230630xex31d2.htm EX-31.2 10614
6 EX-32.1 xoma-20230630xex32d1.htm EX-32.1 8729
  Complete submission text file 0001558370-23-013756.txt   11575451

Data Files

Seq Description Document Type Size
7 EX-101.SCH xoma-20230630.xsd EX-101.SCH 94412
8 EX-101.CAL xoma-20230630_cal.xml EX-101.CAL 47607
9 EX-101.DEF xoma-20230630_def.xml EX-101.DEF 485393
10 EX-101.LAB xoma-20230630_lab.xml EX-101.LAB 654221
11 EX-101.PRE xoma-20230630_pre.xml EX-101.PRE 650063
90 EXTRACTED XBRL INSTANCE DOCUMENT xoma-20230630x10q_htm.xml XML 1852356
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 231149374
SIC: 2834 Pharmaceutical Preparations